Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study

被引：0
|
作者：
Kazuaki Enya
Ben T. Saji
Takuya Kato
Hiroyuki Okamoto
Emiko Koumura
机构：
[1] Takeda Pharmaceutical Co. Ltd,Japan Development Center
[2] Toho University Omori Medical Center,First Department of Pediatrics
[3] Takeda Pharmaceutical Co. Ltd,Formerly Japan Development Center
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Angiotensin II receptor blocker; Azilsartan; Cardiology; Hypertension; Pediatric; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1181 / 1190
页数：9
相关论文
共 50 条
  • [31] PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF ENSIFENTRINE IN HEALTHY CHINESE ADULTS: A PHASE 1, OPEN-LABEL, SINGLE AND MULTIPLE DOSE STUDY
    Meng, Haijin
    Li, Xin
    Chen, Charlie
    Cheng, Cecilia
    Zhang, Ping
    Yuan, Chenchen Zhang
    CHEST, 2024, 166 (04) : 4758A - 4758A
  • [32] Open-Label, Dose-Escalation, Phase 1 Study of Safety and Single and Multiple-Dose Pharmacokinetics of Dichlorphenamide in Healthy Volunteers
    Cohen, Fredric
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 87 - 94
  • [33] A Phase 1, Open-Label, Single-Dose Pharmacokinetic Study of Lasmiditan in Paediatric Patients with Migraine
    Tsai, Max
    Nery, Emel Serap Monkul
    Kerr, Lisa
    Khanna, Rashna
    Komori, Mika
    Dennehy, Ellen
    Wilbraham, Darren
    NEUROLOGY, 2021, 96 (15)
  • [34] A PHASE 1, OPEN-LABEL, SINGLE-DOSE PHARMACOKINETIC STUDY OF LASMIDITAN IN PAEDIATRIC PATIENTS WITH MIGRAINE
    Tsai, Max
    Nery, Emel Serap Monkul
    Kerr, Lisa
    Khanna, Rashna
    Komori, Mika
    Dennehy, Ellen B.
    Wilbraham, Darren
    CEPHALALGIA, 2020, 40 : 41 - 42
  • [35] A Randomized, Multicenter, Open-Label Phase 3 Study to Evaluate the Safety and Efficacy of Infliximab in Pediatric Patients With Moderate to Severe Ulcerative Colitis
    Hyarns, Jeffrey S.
    Damaraju, Lakshmi
    Blank, Marion
    Johanns, Jewel
    Guzzo, Cynthia
    Winter, Harland S.
    Kugathasan, Sabra
    Cohen, Stanley A.
    Markowitz, James
    Veereman, Gigi
    Crandall, Wallace
    Baldassano, Robert
    Griffiths, Anne M.
    GASTROENTEROLOGY, 2011, 140 (05) : S124 - S125
  • [36] Phase 1, Open-Label, Dose Escalation, Safety, and Pharmacokinetics Study of ME-344 as a Single Agent in Patients With Refractory Solid Tumors
    Bendell, Johanna C.
    Patel, Manish R.
    Infante, Jeffrey R.
    Kurkjian, Carla D.
    Jones, Suzanne F.
    Pant, Shubham
    Burris, Howard A., III
    Moreno, Ofir
    Esquibel, Vanessa
    Levin, Wendy
    Moore, Kathleen N.
    CANCER, 2015, 121 (07) : 1056 - 1063
  • [37] Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease
    Doody, RS
    Geldmacher, DS
    Gordon, B
    Perdomo, CA
    Pratt, RD
    ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 427 - 433
  • [38] Eculizumab in Adolescent Patients With Refractory Generalized Myasthenia Gravis: A Phase 3, Open-Label, Multicenter Study
    Brandsema, John F.
    Ginsberg, Matthew
    Hoshino, Hideki
    Mimaki, Masakazu
    Nagata, Satoru
    Rao, Vamshi K.
    Ruzhansky, Katherine
    Suresh, Niraja
    Tiongson, Emmanuelle
    Yamanouchi, Hideo
    Frick, Glen
    Hicks, Eden
    Liao, Serena
    Howard, James F.
    PEDIATRIC NEUROLOGY, 2024, 156 : 198 - 207
  • [39] A phase 3, multicenter, open-label safety study of vernakalant hydrochloride injection in patients with atrial fibrillation
    Stiell, I. G.
    Badenhorst, J. C. W.
    Kitt, T. M.
    Engel, D.
    EUROPEAN HEART JOURNAL, 2007, 28 : 809 - 809
  • [40] HAVEN 2 Updated Analysis: Multicenter, Open-Label, Phase 3 Study to Evaluate Efficacy, Safety and Pharmacokinetics of Subcutaneous Administration of Emicizumab Prophylaxis in Pediatric Patients with Hemophilia A with Inhibitors
    Young, Guy
    Sidonio, Robert F.
    Liesner, Ri
    Oldenburg, Johannes
    Chang, Tiffany
    Uguen, Marianne
    Dhalluin, Christophe
    Schmitt, Christophe
    Levy, Gallia G.
    Shima, Midori
    Mahlangu, Johnny
    BLOOD, 2017, 130
12345